跳至主要内容
临床试验/NL-OMON45901
NL-OMON45901已完成4 期

Fresh Intravenous Blood Samples for TBI Diagnostic Assay Development with Philips Point of Care System (FIRST DOWN)* - FIRST DOW

Banyan Biomarkers, Inc0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. The Subject is at least 18 years of age at screening.
  • 2. The Subject has presented to a Health Care Facility (HCF) or Emergency Department (ED) with a suspected traumatically induced head injury, as a result of insult to the head from an external force.
  • 3. The Subject has a Glasgow Coma Scale score of 9-15 at the time of Informed Consent.
  • 4. The venous blood sample is collected no later than 12 hours from the time of head injury.
  • 5. The Subject or their Next of Kin is willing to undergo the Informed Consent process prior to enrollment into this study

排除标准

  • 1. Participating in any other interventional, therapeutic clinical study (an observational study would be acceptable).
  • 2. Time of suspected head injury cannot be determined.
  • 3. Venipuncture not feasible (i.e., skin integrity compromised at the venipuncture sites, blood vessel calcification (i.e., IV drug users, advanced atherosclerosis) both upper limbs missing (congenital or amputee)).
  • 4. Blood transfusion after head injury, and prior to study blood draw
  • 5. Blood donation within 1 week of study enrollment.
  • 6. The subject is a female who is pregnant or lactating.
  • 7. The Subject is otherwise determined by the Principal Investigator to be an unsuitable candidate for participation

研究者

相似试验